Now Pfizer Is Rumored To Be Interested In Protalix (PLX)
Down)
According to reports from the Globes Online, Pfizer (NYSE: PFE) could be interested in buying Protalix Biotherapeutics Inc. (AMEX: PLX) after representatives of Pfizer visited Protalix's plant in Carmiel in the past few day.
The Pfizer rumors spring up after recent rumor that Teva Pharmaceutical (Nasdaq: TEVA) is also considering buying Protalix.
The companies appear to be interested in Protalix's treatment for Guacher's disease.
Link to Globes Online Article
The Pfizer rumors spring up after recent rumor that Teva Pharmaceutical (Nasdaq: TEVA) is also considering buying Protalix.
The companies appear to be interested in Protalix's treatment for Guacher's disease.
Link to Globes Online Article
You May Also Be Interested In
- Teva Provides Updated 2012 Non-GAAP Financial Outlook; Updated 2012 Non-GAAP Diluted EPS of $5.30 to $5.40
- Teva to Host Conference Call and Webcast on May 24, 2012
- DealReporter Says Diamond Foods (DMND) to Receive PIPE Investment from Oaktree; Shares Moving Higher
Create E-mail Alert Related Categories
RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
